Table 3

Medications monitored in the MULTI sTUdy Diabetes rEsearch Consortium

Data sets	ACCORD	AFFIRM	BARI 2D	ARIC	JHS	FHS cohort	FHS offspring	FHS Gen3	FOCUS	MRFIT	ALL HAT	BHS	CORAL	NGHS	OMNI heart	POWER-UP	SPRINT-POP
Any T2DM medication	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+
Insulin	+		+		+	+	+	+	+	+		+	+	+	+
Oral medications	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+
Biguanides	+	+	+			+	+	+
Sulfonylureas	+	+	+			+	+	+
Meglitinides	+		+			+	+	+
Alpha-glucosidase inhibitors	+
Thiazolidinediones	+	+	+			+	+	+
DPP4 inhibitor			+
Incretin mimetic			+
Any dyslipidaemia medication	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+
Statins	+	+	+	+		+	+	+			+	+	+	+			+
Fibrates	+		+			+	+	+		+				+
Niacin and nicotinic acid	+		+			+	+	+		+				+
Any CVD medication	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+	+
Aspirin	+	+	+	+	+	+	+	+			+		+				+
Other inhibitors of platelet aggregation/anticoagulant	+	+	+		+	+	+	+		+			+
Diuretic	+	+	+			+	+	+		+	+		+				+
ACE inhibitor	+	+	+	+		+	+	+			+		+				+
ARB	+	+	+			+	+	+					+				+
Beta blocker	+	+	+	+		+	+	+		+	+		+				+
Calcium channel blocker	+	+	+			+	+	+					+				+
Peripheral alpha blocker	+					+	+	+		+	+		+				+
Central alpha-adrenergic agonist	+					+	+	+		+	+		+				+
Nitrates	+	+	+	+		+	+	+		+							+
Antiarrhythmic	+	+		+		+	+	+		+					+
Potassium supplements	+	+				+	+	+		+	+				+
Any endocrine/metabolic medication	+	+		+		+	+	+				+		+
Progestin/oestrogens/ birth control pills	+	+				+	+	+				+		+
Glucocorticoids												+
Androgens												+

ACCORD, Action to Control Cardiovascular Risk in Diabetes; AFFIRM, Atrial Fibrillation Follow-Up Investigation of Rhythm Management; ALLHAT, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial; ARB, angiotensin receptor blockers; ARIC, Atherosclerosis Risk in Communities; BARI 2D, Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes; BHS, Bogalusa Heart Study; CORAL, Cardiovascular Outcomes in Renal Atherosclerotic Lesions; CVD, cardiovascular disease; DPP4, dipeptidyl peptidase 4; FHS, Framingham Heart Study; FOCUS, Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair; JHS, Jackson Heart Study; MRFIT, Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease; NGHS, NHLBI Growth and Health Study; OMNI heart, Optimal Macronutrient Intake Trial to Prevent Heart Disease; POWER-UP, Practice Based Opportunities for Weight Reduction Trial at the University of Pennsylvania; SPRINT-POP, Systolic Blood Pressure Intervention Trial Primary Outcome Paper; T2DM, type 2 diabetes mellitus.